ANTIPROTEINURIC EFFECT OF ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS IN PATIENTS WITH PRIMARY GLOMERULAR-DISEASE AND NORMAL RENAL-FUNCTION

被引：0
作者：
FABBRI, A
COCCHI, R
ESPOSTI, ED
LUCATELLO, A
STURANI, A
TAMPIERI, G
FUSAROLI, M
机构：
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1990年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：81 / 83
页数：3
相关论文
共 50 条
  • [31] Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
    Natale, Patrizia
    Palmer, Suetonia C.
    Navaneethan, Sankar D.
    Craig, Jonathan C.
    Strippoli, Giovanni F. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (04):
  • [32] Angioedema may not be a class side-effect of the angiotensin-converting-enzyme inhibitors
    Karagiannis, A
    Pyrpasopoulou, A
    Tziomalos, K
    Florentin, M
    Athyros, V
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2006, 99 (03) : 197 - 198
  • [33] Reduction of renal function by angiotensin-converting enzyme inhibitors: Effect of verapamil
    Bitar, R
    Martin, B
    LopezNovoa, JM
    MaciasNunez, JF
    NEPHRON, 1997, 75 (04): : 486 - 487
  • [34] Late angio-oedema in patients taking angiotensin-converting-enzyme inhibitors
    Pavletic, AJ
    LANCET, 2002, 360 (9331) : 493 - 494
  • [35] Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
    Maschio, G
    Alberti, D
    Janin, G
    Locatelli, F
    Mann, JFE
    Motolese, M
    Ponticelli, C
    Ritz, E
    Zucchelli, P
    Marai, P
    Marcelli, D
    Tentori, F
    Andriani, M
    Drago, G
    Meneghel, G
    Oldrizzi, L
    Rugiu, C
    Salvadeo, A
    Villa, G
    Picardi, L
    Borghi, M
    Moriggi, M
    Vendramin, G
    Fusaroli, M
    Esposti, ED
    Fabbri, A
    Koch, KM
    Frey, U
    Schaeffer, J
    Mann, J
    Schweitzer, C
    Zuccala, A
    Gaggi, R
    Stahl, R
    Blaser, C
    Rivolta, E
    Buccianti, G
    Gastaldi, L
    Baratelli, M
    Ducret, F
    Pointet, P
    Sterzel, R
    Oberdorf, E
    Pedrini, L
    Faranna, P
    Cairo, G
    Ferrari, L
    Albertazzi, A
    Cappelli, P
    Cantu, P
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) : 939 - 945
  • [36] Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease
    Haas, M
    Yilmaz, N
    Schmidt, A
    Neyer, U
    Arneitz, K
    Stummvoll, HK
    Wallner, M
    Auinger, M
    Arias, I
    Schneider, B
    Mayer, G
    KIDNEY & BLOOD PRESSURE RESEARCH, 1998, 21 (01) : 66 - 69
  • [37] SEVERE REDUCTION OF RENAL-FUNCTION IN HYPERTENSIVES AND/OR DIABETICS INDUCED BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    GOTLOIB, L
    JAICHENKO, S
    FUDIN, R
    SHOSTOK, A
    NEPHRON, 1995, 71 (02): : 230 - 231
  • [38] Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Kidney Function in Patients with Sickle Cell Disease
    Choi, Jun
    Singh, Naina
    Han, Jin
    Gowhari, Michel
    Hassan, Johara
    Jain, Shivi
    Molokie, Robert E.
    Gordeuk, Victor R.
    Saraf, Santosh L.
    BLOOD, 2016, 128 (22)
  • [39] Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease
    Jafar, TH
    Schmid, CH
    Levey, AS
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (04) : 298 - 299
  • [40] ANGIOTENSIN-II RECEPTOR ANTAGONISTS VERSUS ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS - EFFECTS ON RENAL-FUNCTION
    JOVER, B
    MIMRAN, A
    JOURNAL OF HYPERTENSION, 1994, 12 : S3 - S9
12345